428
Participants
Start Date
January 4, 2021
Primary Completion Date
December 14, 2022
Study Completion Date
November 8, 2023
Skin Biopsy
Test accuracy and precision of skin biopsy detection of phosphorylated α-synuclein, define sensitivity and specificity of skin biopsy detection of phosphorylated α-synuclein deposition for the diagnosis of synucleinopathies and to differentiate between the synucleinopathies by quantitative measurement of phosphorylated α-synuclein with skin biopsies.
NYU Medical Center, New York
SouthShore Neurologic, Patchogue
Duke University Medical Center, Durham
UF College of Medicine, Gainesville
Aventura Neurology, Aventura
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
Parkinson's Disease Treatment Center SWFL, Port Charlotte
Vanderbilt University Medical Center, Nashville
Mayo Clinic, Rochester
NorthShore University Health System, Evanston
UTSouthwestern, Dallas
Texas Movement Disorders Specialists, Georgetown
Rocky Mountain Movement Disorders Center, PC, Englewood
CND Life Sciences, Phoenix
Movement Disorders Center of Arizona, Scottsdale
MD First Research, Chandler
Providence St. John's Health, Santa Monica
The Neuro Center, Carlsbad
Providence Brain & Spine Institute, Portland
Evergreen Health, Kirkland
Swedish Neuroscience Research, Seattle
Boston Medical Center, Boston
Beth Israel Lahey Health, Boston
Lead Sponsor
CND Life Sciences
OTHER